2023
DOI: 10.3389/fonc.2022.1055308
|View full text |Cite
|
Sign up to set email alerts
|

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration

Abstract: IntroductionDysregulation of cell cycle progression (CCP) is a trait that distinguishes cancer from other diseases. In several cancer types, CCP-related genes serve as the primary risk factor for prognosis, but their role in cutaneous melanoma remains unclear.MethodsData from cutaneous melanoma patients were acquired from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). Using a Wilcoxon test, the level of CCP-related gene expression in cutaneous melanoma patient tissues was compared to that in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 41 publications
0
2
0
Order By: Relevance
“…R software, a statistically sound program with extensive literature documentation, was used for data processing (version 4.2.1). Every statistical and data processing technique has reference to earlier publications in the literature [ 12 , 22 , 27 ]. The t-test was used to compare groups, and P < 0.05 was chosen as the threshold for statistical significance.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…R software, a statistically sound program with extensive literature documentation, was used for data processing (version 4.2.1). Every statistical and data processing technique has reference to earlier publications in the literature [ 12 , 22 , 27 ]. The t-test was used to compare groups, and P < 0.05 was chosen as the threshold for statistical significance.…”
Section: Methodsmentioning
confidence: 99%
“…Inappropriate cell cycle progression can lead to unchecked cell proliferation and the advancement of cancer, particularly at critical checkpoints like G1/S and G2/M [ 11 ]. Dysregulation of CCP is implicated in various diseases, including cancer [ 12 14 ]. Aberrations in genes governing CCP and apoptotic pathways contribute to tumorigenesis and progression [ 15 , 16 ].…”
Section: Introductionmentioning
confidence: 99%